Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 75 Records) |
| Query Trace: Neoplasms and RNF43[original query] |
|---|
| RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF metastatic colorectal cancer. Nature medicine 2022 9 28 (10): 2162-2170. Elez Elena, Ros Javier, Fernández Jose, Villacampa Guillermo, Moreno-Cárdenas Ana Belén, Arenillas Carlota, Bernatowicz Kinga, Comas Raquel, Li Shanshan, Kodack David Philip, Fasani Roberta, Garcia Ariadna, Gonzalo-Ruiz Javier, Piris-Gimenez Alejandro, Nuciforo Paolo, Kerr Grainne, Intini Rossana, Montagna Aldo, Germani Marco Maria, Randon Giovanni, Vivancos Ana, Smits Ron, Graus Diana, Perez-Lopez Raquel, Cremolini Chiara, Lonardi Sara, Pietrantonio Filippo, Dienstmann Rodrigo, Tabernero Josep, Toledo Rodrigo |
| Pancancer analysis of a potential gene mutation model in the prediction of immunotherapy outcomes. Frontiers in genetics 2022 9 13 917118. Yu Lishan, Gong Caife |
| Exome sequencing revealed comparable frequencies of RNF43 and BRAF mutations in Middle Eastern colorectal cancer. Scientific reports 2022 Jul 12 (1): 13098. Siraj Abdul Khalid, Bu Rong, Masoodi Tariq, Parvathareddy Sandeep Kumar, Iqbal Kaleem, Al-Haqawi Wael, Al-Dossari Hassan, Azam Saud, Qadri Zeeshan, Annaiyappanaidu Padmanaban, Al-Dayel Fouad, Al-Kuraya Khawla Sa |
| Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitors. Therapeutic advances in medical oncology 2022 6 14 17588359221105022. Xu Ting, Wang Xicheng, Wang Zhenghang, Deng Ting, Qi Changsong, Liu Dan, Li Yanyan, Ji Congcong, Li Jian, Shen L |
| Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer. British journal of cancer 2022 Jun . Hashimoto Taiki, Takayanagi Daisuke, Yonemaru Junpei, Naka Tomoaki, Nagashima Kengo, Yatabe Yasushi, Shida Dai, Hamamoto Ryuji, Kleeman Sam O, Leedham Simon J, Maughan Timothy, Takashima Atsuo, Shiraishi Kouya, Sekine Shige |
| Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction. Frontiers in oncology 2022 11 12 941868. Lao Yueqiong, Wang Yuqian, Yang Jie, Liu Tianyuan, Ma Yuling, Luo Yingying, Sun Yanxia, Li Kai, Zhao Xuan, Niu Xiangjie, Xi Yiyi, Zhong |
| Gene panel testing detects important genetic alterations in ulcerative colitis-associated colorectal neoplasia. Oncology letters 2022 11 24 (6): 442. Shimada Yoshifumi, Nakano Mae, Mizuno Ken-Ichi, Yokoyama Junji, Matsumoto Akio, Tanaka Kana, Oyanagi Hidehito, Nakano Masato, Hirose Yuki, Ichikawa Hiroshi, Sakata Jun, Kameyama Hitoshi, Takii Yasumasa, Sugai Mika, Ling Yiwei, Takeuchi Shiho, Okuda Shujiro, Terai Shuji, Ajioka Yoichi, Wakai Toshifu |
| Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2022 Sep 65 100883. Ye Liu-Fang, Huang Zi-Yao, Chen Xiao-Xi, Chen Zhi-Gang, Wu Si-Xian, Ren Chao, Hu Ming-Tao, Bao Hua, Jin Ying, Wang Feng, Wang Feng-Hua, Du Zi-Ming, Wu Xue, Ju Huai-Qiang, Shao Yang, Li Yu-Hong, Xu Rui-Hua, Wang De-Sh |
| RNF43 is associated with genomic features and clinical outcome in BRAF mutant colorectal cancer. Frontiers in oncology 2023 7 13 1119587. Peipei Shang, Jiongjiong Lu, Feihong Song, Yijun Zhao, Weipeng Hong, Yuange He, Weidong Shen, Li Ge |
| Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910. Cancer science 2023 5 . Dai Shida, Aya Kuchiba, Tatsuhiro Shibata, Tetsuya Hamaguchi, Satoshi Yamasaki, Masaaki Ito, Takaya Kobatake, Toru Tonooka, Tadahiko Masaki, Manabu Shiozawa, Yasumasa Takii, Hiroyuki Uetake, Shu Okamura, Hitoshi Ojima, Shinsuke Kazama, Hiroshi Takeyama, Keisuke Kanato, Yasuhiro Shimada, Yoshinori Murakami, Yukihide Kanemit |
| Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer center network. Molecular oncology 2023 4 . Núria Mulet Margalef, Carmen Castillo, Miguel Mosteiro, Xavier Pérez, Susana Aguilar, Fiorella Ruíz-Pace, Marta Gil, Carmen Cuadra, José Carlos Ruffinelli, Mercedes Martínez, Ferran Losa, Gema Soler, Àlex Teulé, Roser Castany, Rosa Gallego, Andrea Ruíz, Elena Garralda, Elena Élez, Ana Vivancos, Josep Tabernero, Ramon Salazar, Rodrigo Dienstmann, Cristina Sant |
| Differences in DNA damage repair gene mutations between left- and right-sided colorectal cancer. Cancer medicine 2023 4 . Wei Huang, Wenliang Li, Ning Xu, Hui Li, Zihan Zhang, Xiaolong Zhang, Tingting He, Jicheng Yao, Mian Xu, Qingqing He, Lijie Guo, Sen Zha |
| Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. Cancer medicine 2023 3 . Zhao Zhiming, Li Xiaomo, Wang Fei, Xu Yong, Liu Si, Han Quanli, Yang Zhiying, Huang Weiwei, Yin Zhuzeng, Liu Qu, Tan Haidong, Ma Tonghui, Si Shuang, Huang Jia, Yuan Hongling, Li Wei, Liu Ro |
| Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma. Molecular and cellular probes 2023 2 67 101897. Wang Wentao, Zhang Dongyuan, Chang Donglei, Li Yupeng, Ren L |
| The tumor biological significance of RNF43 and LRP1B in gastric cancer is complex and context-dependent. Scientific reports 2023 2 13 (1): 3191. Holm Bente, Barsuhn Stephan, Behrens Hans-Michael, Krüger Sandra, Röcken Christo |
| Somatic mutations can induce a noninflamed tumour microenvironment via their original gene functions, despite deriving neoantigens. British journal of cancer 2023 2 128 (6): 1166-1175. Ishino Takamasa, Kawashima Shusuke, Tanji Etsuko, Ueno Toshihide, Ueda Youki, Ogasawara Sadahisa, Sato Kazuhito, Mano Hiroyuki, Ishihara Soichiro, Kato Naoya, Kawazu Masahito, Togashi Yosu |
| RNF43 mutation as a predictor of immunotherapeutic efficacy in colorectal cancer. American journal of cancer research 2023 12 13 (11): 5549-5558. Kaibin Huang, Shunkai Ding, Kai Chen, Chunhua Guo, Mingyi Wu, Rui Zhang, Luolin Wang, Yuxiang Fu, Jinfeng Xiao, Xianming L |
| WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer. International journal of radiation oncology, biology, physics 2023 1 . Sutera Philip, Deek Matthew P, Van der Eecken Kim, Shetty Amol C, Chang Jin Hee, Hodges Theresa, Song Yang, Verbeke Sofie, Van Dorpe Jo, Fonteyne Valérie, De Laere Bram, Mishra Mark, Rana Zaker, Molitoris Jason, Ferris Matthew, Ross Ashley, Schaeffer Edward, Roberts Nicholas, Song Daniel Y, DeWeese Theodore, Pienta Kenneth J, Antonarakis Emmanuel S, Ost Piet, Tran Phuoc |
| The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer. Journal of clinical medicine 2023 1 12 (2): . Fang Bangwei, Wei Yu, Pan Jian, Zhang Tingwei, Ye Dingwei, Zhu Y |
| Duodenal Fluid Analysis as a Rewarding Approach to Detect Low-Abundance Mutations in Biliopancreatic Cancers. International journal of molecular sciences 2024 8 25 (15): . Francesca Tavano, Anna Latiano, Orazio Palmieri, Domenica Gioffreda, Tiziana Latiano, Annamaria Gentile, Matteo Tardio, Tiziana Pia Latiano, Marco Gentile, Fulvia Terracciano, Francesco Per |
| Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer. Journal of translational medicine 2024 7 22 (1): 646. Christin Lund-Andersen, Annette Torgunrud, Chakravarthi Kanduri, Vegar J Dagenborg, Ida S Frøysnes, Mette M Larsen, Ben Davidson, Stein G Larsen, Kjersti Flatma |
| Whole-exome sequencing reveals novel cancer genes and actionable targets in biliary tract cancers in primary sclerosing cholangitis. Hepatology communications 2024 7 8 (7): . Marit M Grimsrud, Michael Forster, Benjamin Goeppert, Georg Hemmrich-Stanisak, Irmi Sax, Krzysztof Grzyb, Peder R Braadland, Alphonse Charbel, Carmen Metzger, Thomas Albrecht, Tim Alexander Steiert, Matthias Schlesner, Michael P Manns, Arndt Vogel, Sheraz Yaqub, Tom H Karlsen, Peter Schirmacher, Kirsten M Boberg, Andre Franke, Stephanie Roessler, Trine Folsera |
| Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer. Prostate cancer and prostatic diseases 2024 7 . Amanda Broderick, Elizabeth Pan, Jinju Li, Alec Chu, Clara Hwang, Pedro C Barata, Frank Cameron Cackowski, Matthew Labriola, Alyssa Ghose, Mehmet Asim Bilen, Deepak Kilari, Bicky Thapa, Michael Piero, Laura Graham, Abhishek Tripathi, Rohan Garje, Vadim S Koshkin, Erik Hernandez, Tanya B Dorff, Michael Thomas Schweizer, Ajjai Shivaram Alva, Rana R McKay, Andrew J Armstro |
| Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancer. The oncologist 2024 6 . Madappa N Kundranda, Ariane C Kemkes, Mark C Evans, Cynthia A Flannery, David W Hall, Jess R Hoag, Nishitha Therala, Snehal G Thakkar, Jean-Paul De La |
| Comprehensive characterization of MCL-1 in patients with colorectal cancer: Expression, molecular profiles, and outcomes. International journal of cancer 2024 12 . Pooja Mittal, Francesca Battaglin, Yasmine Baca, Joanne Xiu, Alex Farrell, Shivani Soni, Jae Ho Lo, Lesly Torres-Gonzalez, Sandra Algaze, Priya Jayachandran, Karam Ashouri, Alexandra Wong, Wu Zhang, Jian Yu, Lin Zhang, Benjamin A Weinberg, Emil Lou, Anthony F Shields, Richard M Goldberg, John L Marshall, Sanjay Goel, Indrakant K Singh, Heinz-Josef Le |
| Gender-Based Differences in the Efficacy of Anti-EGFR/BRAF/MEK Targeted Therapy in Patients with BRAF-Mutated Metastatic Colorectal Cancer. Seminars in oncology 2024 12 . Laura Pala, Tommaso De Pas, Emilia Cocorocchio, Chiara Catania, Giovanni Ceresoli, Daniele Laszlo, Emma Zattarin, Giovanna Rossi, Fabio Confor |
| Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer. Molecular cancer 2024 11 23 (1): 264. Luís Nunes, Jakob Mørkved Stenersen, Kushtrim Kryeziu, Tobias Sjöblom, Bengt Glimelius, Ragnhild A Lothe, Anita Sve |
| Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study. EBioMedicine 2024 10 109 105373. Rémy Nicolle, Cindy Canivet, Laurent Palazzo, Bertrand Napoléon, Mira Ayadi, Camille Pignolet, Jérôme Cros, Sophie Gourgou, Janick Selves, Jérôme Torrisani, Nelson Dusetti, Pierre Cordelier, Louis Buscail, Barbara Bournet, |
| Analysis of actionable gene fusions in a large cohort of Chinese patients with colorectal cancer. Gastroenterology report 2024 10 12 goae092. Fu-Rong Kou, Jian Li, Zheng-Hang Wang, Ting Xu, Juan-Juan Qian, En-Li Zhang, Li-Jun Zhang, Lin Shen, Xi-Cheng Wa |
| Identification of clinicopathological-specific driver gene and genetic subtyping of colorectal cancer. Cancer science 2025 1 . Jianjiong Li, Chunnian Wang, Changshun Yang, Hua Bao, Ningyou Li, Xianqiang Huang, Wei Gong, Xinyue Hong, Jiani C Yin, Jiaohui Pang, Meifu Gan, Danping Yu |
- Page last reviewed:Feb 1, 2024
- Content source: